Thursday, April 19, 2012

Personalized Medicine approach does not give up!



Breast cancer stems from 10 genetic subtypes, not four as previously thought, according to a study published today in the journal Nature.

Identifying the 10 subtypes means patients in the future will know more exactly which type of breast cancer they have and, as more targeted drugs are developed, they should receive more effective or personalized medicines, said Julia Wilson, head of research information at Breakthrough Breast Cancer.

Well, I really hope that this finding will practically help in cancer treatment. What is missing in this report is the information regarding sampling procedure and dynamics of the cancer development – it can turn out as fiasco if different subtypes can be transformed into each other.

No comments:

Post a Comment